KVACW
FINANCIAL SERVICESKeen Vision Acquisition Corporation Warrant
$0.02+0.00 (+0.00%)PRE
Live · NASDAQ · May 13, Close
AI Insight
What's Moving KVACW Today?
No stock-specific AI insight has been generated for KVACW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.01$0.14
$0.02
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding—
KVACW News
4 articles- Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated CardiomyopathyYahoo Finance·Jul 15, 2025
- Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart SyndromeYahoo Finance·Jun 24, 2025
- Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025Yahoo Finance·Jun 13, 2025
- Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 CongressYahoo Finance·May 19, 2025
All 4 articles loaded
Price Data
Open$0.00
Previous Close$0.02
Day High$0.00
Day Low$0.00
52 Week High$0.14
52 Week Low$0.01
52-Week Range
$0.01$0.14
$0.02
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding—
About Keen Vision Acquisition Corporation Warrant
Keen Vision Acquisition Corporation intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, and related business combination with one or more businesses or entities. The company is headquartered in Summit, New Jersey.
Listed September 15, 2023
FINANCIAL SERVICESBLANK CHECKS
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBLANK CHECKS
CIK—
Composite FIGI—
Share Class FIGI—